Browse Human Gene Sets

Gene set name:

 
  (Enter full or partial name)

By first letter:

 

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

By collection:

[about the MSigDB Human collections]

  • H (hallmark gene sets, 50 gene sets)
  • C1 (positional gene sets, 301 gene sets)
  • C2 (curated gene sets, 7233 gene sets)
    • CGP (chemical and genetic pertubations, 3438 gene sets)
    • CP (canonical pathways, 3795 gene sets)
  • C3 (regulatory gene sets, 3713 gene sets)
    • MIR (microRNA targets, 2598 gene sets)
    • TFT (all transcription factor targets, 1115 gene sets)
      • TFT:GTRD (GTRD transcription factor targets, 505 gene sets)
      • TFT:TFT_LEGACY (legacy transcription factor targets, 610 gene sets)
  • C4 (computational gene sets, 1007 gene sets)
    • 3CA (Curated Cancer Cell Atlas gene sets, 149 gene sets)
    • CGN (cancer gene neighborhoods, 427 gene sets)
    • CM (cancer modules, 431 gene sets)
  • C5 (ontology gene sets, 16008 gene sets)
    • GO (Gene Ontology, 10461 gene sets)
      • GO:BP (GO biological process, 7647 gene sets)
      • GO:CC (GO cellular component, 1015 gene sets)
      • GO:MF (GO molecular function, 1799 gene sets)
    • HPO (Human Phenotype Ontology, 5547 gene sets)
  • C6 (oncogenic gene sets, 189 gene sets)
  • C7 (immunologic gene sets, 5219 gene sets)
    • IMMUNESIGDB (ImmuneSigDB gene sets, 4872 gene sets)
    • VAX (vaccine response gene sets, 347 gene sets)
  • C8 (cell type signature gene sets, 830 gene sets)

Gene sets starting with S

Click on a gene set name to view its gene set page.

S8_01
S_PHASE
S_PHASE_OF_MITOTIC_CELL_CYCLE
SA_B_CELL_RECEPTOR_COMPLEXES
SA_CASPASE_CASCADE
SA_FAS_SIGNALING
SA_G1_AND_S_PHASES
SA_G2_AND_M_PHASES
SA_MMP_CYTOKINE_CONNECTION
SA_PROGRAMMED_CELL_DEATH
SA_PTEN_PATHWAY
SA_REG_CASCADE_OF_CYCLIN_EXPR
SA_TRKA_RECEPTOR
SABATES_COLORECTAL_ADENOMA_DN
SABATES_COLORECTAL_ADENOMA_SIZE_DN
SABATES_COLORECTAL_ADENOMA_SIZE_UP
SABATES_COLORECTAL_ADENOMA_UP
SAENZ_DETOX_PATHWAY_AND_CARCINOGENE
SIS_DN

SAFB2_TARGET_GENES
SAFFORD_T_LYMPHOCYTE_ANERGY
SAGIV_CD24_TARGETS_DN
SAGIV_CD24_TARGETS_UP
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CA
NCER_DN

SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CA
NCER_UP

SAKAI_TUMOR_INFILTRATING_MONOCYTES_
DN

SAKAI_TUMOR_INFILTRATING_MONOCYTES_
UP

SALL4_TARGET_GENES
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_
TNF_THERAPY_NONRESPONDER_POST_TREAT
MENT_DN

SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_
TNF_THERAPY_NONRESPONDER_POST_TREAT
MENT_UP

SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_
TNF_THERAPY_NONRESPONDER_PRE_TREATM
ENT_UP

SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN
SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP
SANA_RESPONSE_TO_IFNG_DN
SANA_RESPONSE_TO_IFNG_UP
SANA_TNF_SIGNALING_DN
SANA_TNF_SIGNALING_UP
SANCHEZ_MDM2_TARGETS
SANDERSON_PPARA_TARGETS
SANSOM_APC_MYC_TARGETS
SANSOM_APC_TARGETS
SANSOM_APC_TARGETS_DN
SANSOM_APC_TARGETS_REQUIRE_MYC
SANSOM_APC_TARGETS_UP
SANSOM_WNT_PATHWAY_REQUIRE_MYC
SARCOMERE
SARRIO_EPITHELIAL_MESENCHYMAL_TRANS
ITION_DN

SARRIO_EPITHELIAL_MESENCHYMAL_TRANS
ITION_UP

SARTIPY_BLUNTED_BY_INSULIN_RESISTAN
CE_DN

SARTIPY_BLUNTED_BY_INSULIN_RESISTAN
CE_UP

SARTIPY_NORMAL_AT_INSULIN_RESISTANC
E_DN

SARTIPY_NORMAL_AT_INSULIN_RESISTANC
E_UP

SASAI_RESISTANCE_TO_NEOPLASTIC_TRAN
SFROMATION

SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
SASAKI_ADULT_T_CELL_LEUKEMIA
SASAKI_TARGETS_OF_TP73_AND_TP63
SASSON_FSH_RESPONSE
SASSON_RESPONSE_TO_FORSKOLIN_DN
SASSON_RESPONSE_TO_FORSKOLIN_UP
SASSON_RESPONSE_TO_GONADOTROPHINS_D
N

SASSON_RESPONSE_TO_GONADOTROPHINS_U
P

SATO_SILENCED_BY_DEACETYLATION_IN_P
ANCREATIC_CANCER

SATO_SILENCED_BY_METHYLATION_IN_PAN
CREATIC_CANCER_1

SATO_SILENCED_BY_METHYLATION_IN_PAN
CREATIC_CANCER_2

SATO_SILENCED_EPIGENETICALLY_IN_PAN
CREATIC_CANCER

SAUL_SEN_MAYO
SCGGAAGY_ELK1_02
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR
_DN

SCHAEFFER_PROSTATE_DEVELOPMENT_12HR
_UP

SCHAEFFER_PROSTATE_DEVELOPMENT_48HR
_DN

SCHAEFFER_PROSTATE_DEVELOPMENT_48HR
_UP

SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_
DN

SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_
UP

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX1_DN

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX1_UP

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX2_DN

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX2_UP

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX3

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX4_DN

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX4_UP

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX5_DN

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX5_UP

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX6_DN

SCHAEFFER_PROSTATE_DEVELOPMENT_AND_
CANCER_BOX6_UP

SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_
DEVELOPMENT_DN

SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_
DEVELOPMENT_UP

SCHAVOLT_TARGETS_OF_TP53_AND_TP63
SCHEIDEREIT_IKK_INTERACTING_PROTEIN
S

SCHEIDEREIT_IKK_TARGETS
SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_2_TO_4DY_DN

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_2_TO_4DY_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_50_TO_60DY_DN

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_50_TO_60DY_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_5_TO_7DY_DN

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_5_TO_7DY_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_40Y
O_5_TO_7DY_DN

SCHERER_PBMC_APSV_WETVAX_AGE_18_40Y
O_5_TO_7DY_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_40Y
O_JOINT_TO_VACCINIA_AND_YELLOW_FEVE
R_UP

SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_T
O_7DY_DN

SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_T
O_7DY_UP

SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANY
D_DN

SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANY
D_UP

SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOI
NT_TO_VACCINIA_AND_YELLOW_FEVER_UP

SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_
AGE_18_40YO_JOINT_TO_VACCINIA_AND_Y
ELLOW_FEVER_DN

SCHLESINGER_H3K27ME3_IN_NORMAL_AND_
METHYLATED_IN_CANCER

SCHLESINGER_METHYLATED_DE_NOVO_IN_C
ANCER

SCHLESINGER_METHYLATED_IN_COLON_CAN
CER

SCHLINGEMANN_SKIN_CARCINOGENESIS_TP
A_DN

SCHLINGEMANN_SKIN_CARCINOGENESIS_TP
A_UP

SCHLOSSER_MYC_AND_SERUM_RESPONSE_SY
NERGY

SCHLOSSER_MYC_TARGETS_AND_SERUM_RES
PONSE_DN

SCHLOSSER_MYC_TARGETS_AND_SERUM_RES
PONSE_UP

SCHLOSSER_MYC_TARGETS_REPRESSED_BY_
SERUM

SCHLOSSER_SERUM_RESPONSE_AUGMENTED_
BY_MYC

SCHLOSSER_SERUM_RESPONSE_DN
SCHLOSSER_SERUM_RESPONSE_UP
SCHMAHL_PDGF_SIGNALING
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP
SCHOEN_NFKB_SIGNALING
SCHRAETS_MLL_TARGETS_DN
SCHRAETS_MLL_TARGETS_UP
SCHRAMM_INHBA_TARGETS_DN
SCHUETZ_BREAST_CANCER_DUCTAL_INVASI
VE_DN

SCHUETZ_BREAST_CANCER_DUCTAL_INVASI
VE_UP

SCHUHMACHER_MYC_TARGETS_DN
SCHUHMACHER_MYC_TARGETS_UP
SCHURINGA_STAT5A_TARGETS_UP
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_
VARIANTS_DN

SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_
VARIANTS_UP

SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AN
D_TP73_DN

SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AN
D_TP73_UP

SCIAN_INVERSED_TARGETS_OF_TP53_AND_
TP73_DN

SCIAN_INVERSED_TARGETS_OF_TP53_AND_
TP73_UP

SCIBETTA_KDM5B_TARGETS_DN
SCIBETTA_KDM5B_TARGETS_UP
SEAVEY_EPITHELIOID_HEMANGIOENDOTHEL
IOMA

SECRETION_BY_CELL
SECRETORY_PATHWAY
SEF1_C
SEIDEN_MET_SIGNALING
SEIDEN_ONCOGENESIS_BY_MET
SEIKE_LUNG_CANCER_POOR_SURVIVAL
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_
8P_DELETION_DN

SEITZ_NEOPLASTIC_TRANSFORMATION_BY_
8P_DELETION_UP

SEKI_INFLAMMATORY_RESPONSE_LPS_DN
SEKI_INFLAMMATORY_RESPONSE_LPS_UP
SEMBA_FHIT_TARGETS_DN
SEMBA_FHIT_TARGETS_UP
SEMENZA_HIF1_TARGETS
SENESE_HDAC1_AND_HDAC2_TARGETS_DN
SENESE_HDAC1_AND_HDAC2_TARGETS_UP
SENESE_HDAC1_TARGETS_DN
SENESE_HDAC1_TARGETS_UP
SENESE_HDAC2_TARGETS_DN
SENESE_HDAC2_TARGETS_UP
SENESE_HDAC3_TARGETS_DN
SENESE_HDAC3_TARGETS_UP
SENGUPTA_EBNA1_ANTICORRELATED
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_D
N

SENGUPTA_NASOPHARYNGEAL_CARCINOMA_U
P

SENGUPTA_NASOPHARYNGEAL_CARCINOMA_W
ITH_LMP1_DN

SENGUPTA_NASOPHARYNGEAL_CARCINOMA_W
ITH_LMP1_UP

SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY
SERINE_TYPE_PEPTIDASE_ACTIVITY
SERVITJA_ISLET_HNF1A_TARGETS_DN
SERVITJA_ISLET_HNF1A_TARGETS_UP
SERVITJA_LIVER_HNF1A_TARGETS_DN
SERVITJA_LIVER_HNF1A_TARGETS_UP
SESTO_RESPONSE_TO_UV_C0
SESTO_RESPONSE_TO_UV_C1
SESTO_RESPONSE_TO_UV_C2
SESTO_RESPONSE_TO_UV_C3
SESTO_RESPONSE_TO_UV_C4
SESTO_RESPONSE_TO_UV_C5
SESTO_RESPONSE_TO_UV_C6
SESTO_RESPONSE_TO_UV_C7
SESTO_RESPONSE_TO_UV_C8
SETBP1_TARGET_GENES
SETD1A_TARGET_GENES
SETD7_TARGET_GENES
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_
FUSION_DN

SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_
FUSION_UP

SF1_Q6
SFMBT1_TARGET_GENES
SGCGSSAAA_E2F1DP2_01
SH3_SH2_ADAPTOR_ACTIVITY
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGR
AM

SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B
_LYMPHOCYTE

SHAFFER_IRF4_TARGETS_IN_ACTIVATED_D
ENDRITIC_CELL

SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_
MATURE_B_LYMPHOCYTE

SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL
_VS_MATURE_B_LYMPHOCYTE

SHANK_TAL1_TARGETS_DN
SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATI
ON_DN

SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATI
ON_UP

SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A
12

SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A
4

SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A
5

SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A
6

SHEN_SMARCA2_TARGETS_DN
SHEN_SMARCA2_TARGETS_UP
SHEPARD_BMYB_MORPHOLINO_DN
SHEPARD_BMYB_MORPHOLINO_UP
SHEPARD_BMYB_TARGETS
SHEPARD_CRASH_AND_BURN_MUTANT_DN
SHEPARD_CRASH_AND_BURN_MUTANT_UP
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PA
M1

SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PA
M2

SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PA
M3

SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PA
M4

SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PA
M5

SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PA
M6

SHI_SPARC_TARGETS_DN
SHI_SPARC_TARGETS_UP
SHIN_B_CELL_LYMPHOMA_CLUSTER_1
SHIN_B_CELL_LYMPHOMA_CLUSTER_2
SHIN_B_CELL_LYMPHOMA_CLUSTER_3
SHIN_B_CELL_LYMPHOMA_CLUSTER_5
SHIN_B_CELL_LYMPHOMA_CLUSTER_6
SHIN_B_CELL_LYMPHOMA_CLUSTER_7
SHIN_B_CELL_LYMPHOMA_CLUSTER_8
SHIN_B_CELL_LYMPHOMA_CLUSTER_9
SHIPP_DLBCL_CURED_VS_FATAL_DN
SHIPP_DLBCL_CURED_VS_FATAL_UP
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_
DN

SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_
UP

SHIRAISHI_PLZF_TARGETS_DN
SHIRAISHI_PLZF_TARGETS_UP
SIG_BCR_SIGNALING_PATHWAY
SIG_CD40PATHWAYMAP
SIG_CHEMOTAXIS
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CAR
DIAC_MYOCYTES

SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCT
ES

SIG_REGULATION_OF_THE_ACTIN_CYTOSKE
LETON_BY_RHO_GTPASES

SIGMAR1_TARGET_GENES
SILIGAN_BOUND_BY_EWS_FLT1_FUSION
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_
DN

SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_
UP

SIMBULAN_PARP1_TARGETS_DN
SIMBULAN_PARP1_TARGETS_UP
SIMBULAN_UV_RESPONSE_IMMORTALIZED_D
N

SIMBULAN_UV_RESPONSE_NORMAL_DN
SIMBULAN_UV_RESPONSE_NORMAL_UP
SINGH_KRAS_DEPENDENCY_SIGNATURE
SINGH_NFE2L2_TARGETS
SIPA1_TARGET_GENES
SIRNA_EIF4GI_DN
SIRNA_EIF4GI_UP
SIRT3_TARGET_GENES
SIX1_TARGET_GENES
SIX4_TARGET_GENES
SKELETAL_MUSCLE_DEVELOPMENT
SKIL_TARGET_GENES
SKP2_TARGET_GENES
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HP
V_UP

SMAD3_Q6
SMAD4_Q6
SMAD_Q6
SMALL_GTPASE_REGULATOR_ACTIVITY
SMALL_PROTEIN_CONJUGATING_ENZYME_AC
TIVITY

SMARCA1_TARGET_GENES
SMCHD1_TARGET_GENES
SMID_BREAST_CANCER_BASAL_DN
SMID_BREAST_CANCER_BASAL_UP
SMID_BREAST_CANCER_ERBB2_DN
SMID_BREAST_CANCER_ERBB2_UP
SMID_BREAST_CANCER_LUMINAL_A_DN
SMID_BREAST_CANCER_LUMINAL_A_UP
SMID_BREAST_CANCER_LUMINAL_B_DN
SMID_BREAST_CANCER_LUMINAL_B_UP
SMID_BREAST_CANCER_NORMAL_LIKE_DN
SMID_BREAST_CANCER_NORMAL_LIKE_UP
SMID_BREAST_CANCER_RELAPSE_IN_BONE_
DN

SMID_BREAST_CANCER_RELAPSE_IN_BONE_
UP

SMID_BREAST_CANCER_RELAPSE_IN_BRAIN
_DN

SMID_BREAST_CANCER_RELAPSE_IN_BRAIN
_UP

SMID_BREAST_CANCER_RELAPSE_IN_LIVER
_DN

SMID_BREAST_CANCER_RELAPSE_IN_LIVER
_UP

SMID_BREAST_CANCER_RELAPSE_IN_LUNG_
DN

SMID_BREAST_CANCER_RELAPSE_IN_LUNG_
UP

SMID_BREAST_CANCER_RELAPSE_IN_PLEUR
A_DN

SMID_BREAST_CANCER_RELAPSE_IN_PLEUR
A_UP

SMIRNOV_CIRCULATING_ENDOTHELIOCYTES
_IN_CANCER_DN

SMIRNOV_CIRCULATING_ENDOTHELIOCYTES
_IN_CANCER_UP

SMIRNOV_RESPONSE_TO_IR_2HR_DN
SMIRNOV_RESPONSE_TO_IR_2HR_UP
SMIRNOV_RESPONSE_TO_IR_6HR_DN
SMIRNOV_RESPONSE_TO_IR_6HR_UP
SMITH_LIVER_CANCER
SMITH_TERT_TARGETS_DN
SMITH_TERT_TARGETS_UP
SMN1_SMN2_TARGET_GENES
SMTTTTGT_UNKNOWN
SNACANNNYSYAGA_UNKNOWN
SNAI1_TARGET_GENES
SNAPC2_TARGET_GENES
SNAPC4_TARGET_GENES
SNF5_DN.V1_DN
SNF5_DN.V1_UP
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK
_TUMORS

SNIP1_TARGET_GENES
SNRNP70_TARGET_GENES
SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
1DY_UP

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
7DY_DN

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
CORRELATED_WITH_AGE_1DY_POSITIVE

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_
ADVERSE_EVENTS_SCORE_1DY_CORRELATED
_WITH_TRANSITIONAL_B_CELLS_UP

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_
ADVERSE_EVENTS_SCORE_1DY_TRANSIENT_
UP

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
LOW_VS_MEDIUM_HIGH_ADVERSE_EVENT_SU
BJECTS_0DY_DN

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_
1DY_UP

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1D
Y_DN

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
RESPONDERS_VS_NONRESPONDERS_7DY_UP

SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64Y
O_1DY_UP

SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64Y
O_7DY_DN

SOD1_TARGET_GENES
SOGA_COLORECTAL_CANCER_MYC_DN
SOGA_COLORECTAL_CANCER_MYC_UP
SOLUBLE_FRACTION
SONG_TARGETS_OF_IE86_CMV_PROTEIN
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3
_DN

SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3
_UP

SOUCEK_MYC_TARGETS
SOX10_TARGET_GENES
SOX11_TARGET_GENES
SOX15_TARGET_GENES
SOX3_TARGET_GENES
SOX5_01
SOX9_B1
SP1_01
SP1_Q2_01
SP1_Q4_01
SP1_Q6
SP1_Q6_01
SP3_Q3
SPERM_MOTILITY
SPERMATID_DEVELOPMENT
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_AS
IAN_2FC_DN

SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_AS
IAN_2FC_UP

SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_AS
IAN_DN

SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_AS
IAN_UP

SPIRA_SMOKERS_LUNG_CANCER_DN
SPIRA_SMOKERS_LUNG_CANCER_UP
SPZ1_01
SQSTM1_TARGET_GENES
SRC_UP.V1_DN
SRC_UP.V1_UP
SREBP1_01
SREBP1_02
SREBP1_Q6
SREBP_Q3
SRF_01
SRF_C
SRF_Q4
SRF_Q5_01
SRF_Q6
SRPK1_TARGET_GENES
SRPK2_TARGET_GENES
SRSF9_TARGET_GENES
SRY_01
SRY_02
SS18_SSX1_FUSION_UNIPROT_Q8IZH1_UNR
EVIEWED_TARGET_GENES

ST_ADRENERGIC
ST_B_CELL_ANTIGEN_RECEPTOR
ST_DIFFERENTIATION_PATHWAY_IN_PC12_
CELLS

ST_ERK1_ERK2_MAPK_PATHWAY
ST_FAS_SIGNALING_PATHWAY
ST_G_ALPHA_I_PATHWAY
ST_G_ALPHA_S_PATHWAY
ST_GA12_PATHWAY
ST_GA13_PATHWAY
ST_GAQ_PATHWAY
ST_GRANULE_CELL_SURVIVAL_PATHWAY
ST_IL_13_PATHWAY
ST_INTEGRIN_SIGNALING_PATHWAY
ST_INTERFERON_GAMMA_PATHWAY
ST_INTERLEUKIN_4_PATHWAY
ST_JAK_STAT_PATHWAY
ST_JNK_MAPK_PATHWAY
ST_MYOCYTE_AD_PATHWAY
ST_P38_MAPK_PATHWAY
ST_PAC1_RECEPTOR_PATHWAY
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWA
Y

ST_STAT3_PATHWAY
ST_T_CELL_SIGNAL_TRANSDUCTION
ST_TUMOR_NECROSIS_FACTOR_PATHWAY
ST_TYPE_I_INTERFERON_PATHWAY
ST_WNT_BETA_CATENIN_PATHWAY
ST_WNT_CA2_CYCLIC_GMP_PATHWAY
STAEGE_EWING_FAMILY_TUMOR
STAMBOLSKY_BOUND_BY_MUTATED_TP53
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_D
N

STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_U
P

STAMBOLSKY_TARGETS_OF_MUTATED_TP53_
DN

STAMBOLSKY_TARGETS_OF_MUTATED_TP53_
UP

STANELLE_E2F1_TARGETS
STANHILL_HRAS_TRANSFROMATION_UP
STARK_BRAIN_22Q11_DELETION
STARK_HYPPOCAMPUS_22Q11_DELETION_DN
STARK_HYPPOCAMPUS_22Q11_DELETION_UP
STARK_PREFRONTAL_CORTEX_22Q11_DELET
ION_DN

STARK_PREFRONTAL_CORTEX_22Q11_DELET
ION_UP

STAT1_01
STAT1_02
STAT1_03
STAT3_01
STAT3_02
STAT4_01
STAT5A_01
STAT5A_02
STAT5A_03
STAT5A_04
STAT5B_01
STAT6_01
STAT6_02
STAT_01
STAT_Q6
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_
DN

STEARMAN_LUNG_CANCER_EARLY_VS_LATE_
UP

STEARMAN_TUMOR_FIELD_EFFECT_UP
STEGER_ADIPOGENESIS_DN
STEGER_ADIPOGENESIS_UP
STEGMEIER_PREMITOTIC_CELL_CYCLE_REG
ULATORS

STEIN_ESR1_TARGETS
STEIN_ESRRA_TARGETS
STEIN_ESRRA_TARGETS_DN
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_E
STROGEN_DN

STEIN_ESRRA_TARGETS_RESPONSIVE_TO_E
STROGEN_UP

STEIN_ESRRA_TARGETS_UP
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESR
RA

STEINER_ERYTHROCYTE_MEMBRANE_GENES
STK33_DN
STK33_NOMO_DN
STK33_NOMO_UP
STK33_SKM_DN
STK33_SKM_UP
STK33_UP
STN1_TARGET_GENES
STONER_ESOPHAGEAL_CARCINOGENESIS_DN
STONER_ESOPHAGEAL_CARCINOGENESIS_UP
STOSSI_RESPONSE_TO_ESTRADIOL
STREICHER_LSM1_TARGETS_DN
STREICHER_LSM1_TARGETS_UP
STRUCTURE_SPECIFIC_DNA_BINDING
STTTCRNTTT_IRF_Q6
SU_KIDNEY
SU_LIVER
SU_PANCREAS
SU_PLACENTA
SU_SALIVARY_GLAND
SU_TESTIS
SU_THYMUS
SUBTIL_PROGESTIN_TARGETS
SUGAR_BINDING
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP
SUMI_HNF4A_TARGETS
SUMO1_TARGET_GENES
SUNG_METASTASIS_STROMA_DN
SUNG_METASTASIS_STROMA_UP
SUPT16H_TARGET_GENES
SUPT20H_TARGET_GENES
SUZUKI_AMPLIFIED_IN_ORAL_CANCER
SUZUKI_CTCFL_TARGETS_UP
SUZUKI_RESPONSE_TO_TSA
SUZUKI_RESPONSE_TO_TSA_AND_DECITABI
NE_1A

SUZUKI_RESPONSE_TO_TSA_AND_DECITABI
NE_1B

SVIL_TARGET_GENES
SWEET_KRAS_ONCOGENIC_SIGNATURE
SWEET_KRAS_TARGETS_DN
SWEET_KRAS_TARGETS_UP
SWEET_LUNG_CANCER_KRAS_DN
SWEET_LUNG_CANCER_KRAS_UP
SYATTGTG_UNKNOWN
SYED_ESTRADIOL_RESPONSE
SYNAPTIC_TRANSMISSION
SYNAPTIC_VESICLE
SYNCRIP_TARGET_GENES
SYSTEM_DEVELOPMENT
SYSTEM_PROCESS